InvestorsHub Logo
Followers 127
Posts 3172
Boards Moderated 0
Alias Born 08/24/2015

Re: pgsd post# 577518

Friday, 03/17/2023 5:52:08 PM

Friday, March 17, 2023 5:52:08 PM

Post# of 700696
I believe Merck offered $20/share and was turned down after the JAMA-O article came out. I also believe there’s a tentative deal with a capital infusion based on MIA and will be used for new trials, with or without an up listing and with or without a spin off company to get on the NYSE.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News